ADVANCING INCLUSIVE RESEARCH Trademark

Trademark Overview

On Tuesday, February 26, 2019, a trademark application was filed for ADVANCING INCLUSIVE RESEARCH with the United States Patent and Trademark Office. The USPTO has given the ADVANCING INCLUSIVE RESEARCH trademark a serial number of 88316820. The federal status of this trademark filing is REGISTERED as of Tuesday, March 3, 2020. This trademark is owned by Genentech, Inc.. The ADVANCING INCLUSIVE RESEARCH trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific, biological and medical research; Advancing knowledge and developing new approaches through conducting clinical trials for others
advancing inclusive research

General Information

Serial Number88316820
Word MarkADVANCING INCLUSIVE RESEARCH
Filing DateTuesday, February 26, 2019
Status700 - REGISTERED
Status DateTuesday, March 3, 2020
Registration Number6000065
Registration DateTuesday, March 3, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 17, 2019

Trademark Statements

Goods and ServicesScientific, biological and medical research; Advancing knowledge and developing new approaches through conducting clinical trials for others

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 18, 2019
Primary Code042
First Use Anywhere DateTuesday, May 8, 2018
First Use In Commerce DateTuesday, May 8, 2018

Trademark Owner History

Party NameGenentech, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 940804990
Party NameGenentech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameGenentech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Wednesday, April 19, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 19, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, April 19, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 19, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 25, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, August 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 19, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 19, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 19, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 19, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 19, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 3, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, December 17, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 17, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 13, 2019ASSIGNED TO LIE
Friday, November 8, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 6, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 5, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 5, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 14, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 14, 2019NON-FINAL ACTION E-MAILED
Tuesday, May 14, 2019NON-FINAL ACTION WRITTEN
Monday, May 6, 2019ASSIGNED TO EXAMINER
Monday, March 18, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 1, 2019NEW APPLICATION ENTERED

Related Keywords

research inclusive advancing conducting through clinical trials others approaches developing medical biological